TherapeuticsMD (TXMD) Other Non-Current Liabilities (2012 - 2026)
TherapeuticsMD (TXMD) recorded Other Non-Current Liabilities of $873,000 in Q2 2026, up 4.9% from $832,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Starting with Q3 2012, TherapeuticsMD's Other Non-Current Liabilities history includes 26 quarters.
- Annual Other Non-Current Liabilities has a four-year compound annual growth rate of -20.1% (FY2021 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $744,000 in FY2024 (+17.0%), $636,000 in FY2023 (-42.5%), $1.11 million in FY2022 (-48.2%) and $2.14 million in FY2021.
- Quarterly Other Non-Current Liabilities has ranged from $554,000 in Q2 2022 to $2.14 million in Q4 2021 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities has increased for seven consecutive quarters, with growth averaging 10.9% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 114.6% in Q3 2023, against a decline of 48.2% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $873,000 (Q1 2026), $873,000 (Q4 2025) and $871,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn |
| 10 | TherapeuticsMD | 21.41 Mn | 21.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 873,000.00 |
| Mar 31, 2026 | 873,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 871,000.00 |
| Jun 30, 2025 | 832,000.00 |
| Mar 31, 2025 | 795,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 637,000.00 |
| Mar 31, 2024 | 637,000.00 |
| Dec 31, 2023 | 636,000.00 |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Sep 30, 2022 | 554,000.00 |
| Jun 30, 2022 | 554,000.00 |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 758,000.00 |
API Access
TherapeuticsMD Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();